Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does TIPIRACIL\TRIFLURIDINE Cause Neoplasm progression? 41 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 41 reports of Neoplasm progression have been filed in association with TIPIRACIL\TRIFLURIDINE. This represents 0.4% of all adverse event reports for TIPIRACIL\TRIFLURIDINE.

41
Reports of Neoplasm progression with TIPIRACIL\TRIFLURIDINE
0.4%
of all TIPIRACIL\TRIFLURIDINE reports
10
Deaths
9
Hospitalizations

How Dangerous Is Neoplasm progression From TIPIRACIL\TRIFLURIDINE?

Of the 41 reports, 10 (24.4%) resulted in death, 9 (22.0%) required hospitalization.

Is Neoplasm progression Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for TIPIRACIL\TRIFLURIDINE. However, 41 reports have been filed with the FAERS database.

What Other Side Effects Does TIPIRACIL\TRIFLURIDINE Cause?

Death (3,017) Disease progression (1,774) Fatigue (1,298) Nausea (1,135) Diarrhoea (965) Decreased appetite (659) Vomiting (628) White blood cell count decreased (483) Asthenia (472) Anaemia (388)

What Other Drugs Cause Neoplasm progression?

PALBOCICLIB (10,885) SUNITINIB MALATE (1,920) CYCLOPHOSPHAMIDE (1,588) CARBOPLATIN (1,370) AXITINIB (1,315) DOXORUBICIN (1,276) LETROZOLE (1,225) PACLITAXEL (1,180) CRIZOTINIB (1,161) VINCRISTINE (1,106)

Which TIPIRACIL\TRIFLURIDINE Alternatives Have Lower Neoplasm progression Risk?

TIPIRACIL\TRIFLURIDINE vs TIPRANAVIR TIPIRACIL\TRIFLURIDINE vs TIRAGOLUMAB TIPIRACIL\TRIFLURIDINE vs TIRBANIBULIN TIPIRACIL\TRIFLURIDINE vs TIROFIBAN TIPIRACIL\TRIFLURIDINE vs TIRZEPATIDE

Related Pages

TIPIRACIL\TRIFLURIDINE Full Profile All Neoplasm progression Reports All Drugs Causing Neoplasm progression TIPIRACIL\TRIFLURIDINE Demographics